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Decreased Plasma Concentration of Nitric Oxide Metabolites in
Dogs with Untreated Mitral Regurgitation
Henrik D. Pedersen, Trine Schu¨tt, Rikke Søndergaard, Karen Qvortrup, Lisbeth H. Olsen, and
Annemarie T. Kristensen
Endothelium-dependent (nitric oxide [NO]-mediated) vasodilation is impaired in humans with heart failure. This dysfunction is an
important therapeutic target. The plasma concentration of the NO metabolites nitrate and nitrite (collectively referred to as NOx)
is a measure of whole-body NO production, provided that the dietary intake of the ions is low. Fifty clinically healthy dogs older
than 1 year (median 5.0 years; interquartile interval 2.6–8.2 years) were studied, including 9 controls of various breeds, 23 Cavalier
King Charles Spaniels (CKCSs) with no or minimal mitral regurgitation (MR), 9 CKCSs with mild MR (regurgitant jet occupying
15–50% of the left atrial area), and 9 CKCS with moderate to severe MR (jet 50%) due to myxomatous valve disease. None of
the dogs received medication. The dogs were given NOx-free water and a diet with a low concentration of NOx for 96 hours
before blood sampling. Multiple linear regression analysis revealed that dog group, but not gender, age, serum creatinine concen-
tration, and platelet count, was associated with NOx concentrations. Control dogs had the same NOx concentration (median 20.0
M; interquartile interval 15.1–25.5 M) as CKCSs without MR (median 18.7 M; interquartile interval 15.5–25.9 M). Compared
to CKCSs without MR, the NOx concentration was lower in CKCSs with mild (median 12.9 M; interquartile interval 11.0–13.5
M; P  .04) and moderate to severe (median 11.2 M; interquartile interval 6.9–17.1 M; P  .02) MR. In conclusion, CKCSs
with mild to severe, clinically silent MR have decreased plasma NOx concentrations, suggesting that endothelial dysfunction
develops early in the course of developing MR in dogs.
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Nitric oxide (NO) plays a key role in the regulation ofnumerous processes in the body. Vasodilation in re-
sponse to physiologic stimuli such as acetylcholine and in-
creased blood flow is mainly mediated by NO produced in
the endothelium.1,2 Humans with heart failure and dogs with
experimentally induced heart failure have impaired endo-
thelium-dependent vasodilation.2–4 Endothelial dysfunction
is an integral part of the complex pathophysiology of the
development of heart failure, and correction of the condi-
tion is an important therapeutic target.5 In humans, endo-
thelial dysfunction is present early in the course of devel-
oping heart failure, although the etiology of heart failure
seems to be less important.5–7 The presence of endothelial
dysfunction in dogs with naturally occurring heart disease
has not been documented.
Mitral regurgitation (MR) caused by myxomatous mitral
valve disease is the most common cause of heart failure in
dogs. Mitral valve prolapse plays an important role in the
development of myxomatous mitral valve disease.8–10 Mitral
regurgitation has been studied in Cavalier King Charles
Spaniels (CKCSs), which are predisposed to mitral valve
prolapse. Approximately 90% of CKCSs have mitral valve
prolapse at 3–4 years of age and approximately 90% have
auscultatory evidence of MR at 10 years of age.10,11 In ad-
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dition to mitral valve prolapse, approximately one third of
CKCSs have clinically inapparent, inherited thrombocyto-
penia.12 Whether this condition is related in any way to
mitral valve disease in these dogs presently is unclear.
Mitral valve prolapse in dogs, as well as in humans, is
associated with a high renin and low aldosterone profile, an
increased platelet reactivity, and a low plasma magnesium
concentration.8,9 In addition, affected dogs and humans
have an exaggerated respiratory sinus arrhythmia, and mi-
tral valve prolapse may be associated with autonomic dys-
function.13 In the light of this and the central role played
by NO in the circulatory regulation, we investigated en-
dothelial NO production in dogs with mitral valve prolapse.
Nitric oxide is a gaseous free radical, and thus is a very
unstable molecule. The NO radical binds with high affinity
to a variety of other molecules and is rapidly oxidized into
the stable metabolites nitrate and nitrite (collectively re-
ferred to as NOx).14 It is difficult to measure NO directly
and in addition to that, it is difficult to use such measure-
ments to estimate the overall NO turnover in the body. For
this purpose, determination of the stable metabolites can be
used instead, and the plasma NOx concentration appears to
be a good measure of the overall NO production, provided
that the dietary intake of nitrate and nitrite is low and the
patients are fasted.15–20 In fasted healthy humans, as much
as 90% of plasma NOx has been estimated to come from
NO produced by nitric oxide synthase.19
The purpose of this study was to compare the plasma
concentration of NOx in control dogs with that found in
CKCSs with no or minimal MR, and to evaluate whether
the findings in the latter group were influenced by the pres-
ence of thrombocytopenia and the degree of mitral valve
prolapse. Furthermore, the plasma concentration of NOx in
CKCSs with no or minimal MR was compared with that
found in CKCSs with mild to severe, clinically silent MR.
Whether the plasma NOx concentration in CKCSs was as-
sociated with various measures of the degree of MR also
was tested.
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Table 1. Characteristics of the control group and the 41 clinically healthy Cavalier King Charles Spaniels (CKCSs).a
Controls (n  9)
CKCSs
Controls (n  23) Mild MR (n  9)
Moderate to Severe MR
(n  9)
Gender (male/female)
Age (months)
Weight (kg)
Platelets (109/L)
Creatinine (mg/dL)
BUN (mg/dL)
MVP (mm)
LA/Ao ratio
5/4
39 (18–59)
26.5 (18.8–31.5)***
139 (130–150)
1.17 (1.10–1.20)**
10.6 (10.1–12.9)
0.2 (0.7–0.0)***
1.16 (1.12–1.24)
13/10
50 (28–70)
8.0 (7.0–9.0)
115 (77–171)
0.78 (0.60–0.90)
10.9 (7.0–12.3)
0.8 (0.5–1.7)
1.18 (1.10–1.28)
6/3
92 (71–105)
9.6 (8.6–10.4)
223 (107–238)
0.62 (0.60–0.80)
9.2 (7.6–9.5)
1.8 (1.3–2.0)*
1.28 (1.22–1.35)
2/7
123 (86–145)***
8.8 (8.2–9.3)
177 (163–362)*
0.71 (0.60–1.00)
10.9 (9.2–11.2)
2.8 (2.3–3.3)***,§
1.38 (1.28–1.66)***,§
Plasma NOx (M) 20.0 (15.1–25.5) 18.7 (15.5–25.9) 12.9 (11.0–13.5)* 11.2 (6.9–17.1)*
MR, mitral regurgitation; BUN, blood urea nitrogen; MVP, mitral valve prolapse; LA/Ao ratio, left atrial to aortic root ratio; NOx, nitrate 
nitrite.
a Except for gender, data are shown as medians and interquartile intervals.
*, **, and *** indicate statistically different from the 23 CKCS controls (P  .05, P  .01, and P  .001, respectively).
§ Indicates statistically different from the 9 CKCSs with mild MR (P  .05).
Materials and Methods
Dogs and Feeding
Nine clinically healthy control dogs (2 Labrador Retrievers, 2 Pem-
broke Welsh Corgis, 1 Saint Bernard, 1 Wirehaired Dachshund, 1
Bearded Collie, 1 Siberian Husky, and 1 Golden Retriever) and 41
CKCSs were included. All dogs were privately owned, clinically
healthy, without history of disease, receiving no medications, not preg-
nant or lactating, older than 1 year, and without abnormalities on rou-
tine serum biochemistry (Table 1). Additionally, control dogs were
only included if they had no or minimal MR (regurgitant jets occu-
pying 15% of the left atrial area). Fecal specimens from 3 consec-
utive days were examined by using the Baerman technique to ensure
that all dogs were free of Angiostrongylus vasorum infection (which
is found in approximately 3% of dogs in the northern Copenhagen
area). All dogs were examined at the Department of Anatomy and
Physiology at the Royal Veterinary and Agricultural University in Co-
penhagen, Denmark. The CKCSs were divided into 3 groups according
to the size of their regurgitant jets (see later): a group with no or
minimal MR (jets occupying 15% of the left atrial area), a group
with mild MR (15%  jets  50%), and a group with moderate to
severe MR (jets occupying 50% of the left atrial area). In the period
from 96 to 24 hours before blood sampling, the dogs were fed exclu-
sively a dry fooda with a low, controlled content of nitrate and nitrite
(40 and 10 mg/kg, respectively), together with NOx-free water.b In the
last 24 hours before blood sampling, the dogs were given only the
NOx-free water.b The energy content of the diet was 1,580 kJ/100 g,
and the dogs were fed according to the manufacturer’s recommenda-
tions (eg, 200 g/d to a 10-kg dog and 408 g/d to a 25-kg dog).
To assess whether the CKCSs with moderate to severe MR had been
close to developing decompensated heart failure at the time of the
study, the owners of the 9 dogs in that group were telephoned 9
months later, and questioned regarding signs of disease developed in
the period after the study.
Blood Collection and Platelet Counts
Blood samples were taken for NOx analyses as well as for routine
hematologic and biochemical analyses. The samples were taken during
the initial examination, after the dogs had been given approximately
15–45 minutes to acclimatize, and with the owner present next to the
head of the dogs. The samples were collected by jugular venipuncture
with a syringe and needle,c with the dogs in a sitting position. Within
20 seconds, the blood was transferred into a tubed containing a clot
activator and tubesd containing ethylenediaminetetraacetic acid
(EDTA). All samples were centrifuged and plasma was separated with-
in 30 minutes of collection. The plasma was kept frozen at 80C
until NOx analysis.
Within 4 hours from blood sampling, 20 L of the EDTA antico-
agulated blood was mixed with 1.98 mL of a reagent containing am-
monium oxalate to hemolyze red blood cells.e Within 3 hours from
this dilution, the platelets were counted manually with a Bu¨rker Tu¨rk
counting chamber.
Cardiac Examination
All cardiac examinations were performed by one of the authors
(HDP). After the dogs had been given time to acclimatize, they were
auscultated in a standing position. The murmur intensity was graded
1–6.21 Only left apical systolic murmurs are reported here.
Echocardiographyf was performed on all dogs and recorded on a
super-VHS video recorder. The mitral valve was evaluated with a 5.0-
MHz phased-array transducer using the right parasternal long axis 4-
chamber view, with the dogs in right lateral recumbency. The trans-
mitting frequency was optimized according to the size of the dog, to
get the best images of the mitral valve, and attempts were made to
scan all parts of the valve. The left ventricular diameter was assessed
by using M-mode at the level of the chordae tendineae (guided by a
2-dimensional [2-D] short-axis view). To assess the left atrial and aor-
tic root diameter, a 2-D short-axis view at the level of the aortic valve
was used.22 Color-flow mapping of the mitral valve area and left atrium
was made with a 3.5-MHz phased-array transducer using the left cau-
dal 4-chamber view with the dogs in left lateral position. The Doppler
transmitting frequency was 2.2 MHz, and the pulse repetition fre-
quency was adjusted to get an aliasing velocity of 0.8 m/s. The flow
gain was adjusted to the maximal possible level without getting back-
ground noise.
Measurement of NOx
All materials used to store and analyze the plasma samples (pipettes,
tubes, microtiter plates, and so on) were rinsed twice in NOx-free
waterb to remove any contamination with nitrate or nitrite.23 Before
performing the analyses, all samples were thawed and ultrafiltered
twice through 10-kDa filters,g by centrifugation at 14,820  g. The
concentration of NOx was measured with a commercially available
kit.h In brief, nitrate is 1st reduced to nitrite by using nitrate reductase.
The nitrite in the samples is then converted into a purple compound,
and the absorbance is measured at 540 nm. The procedures described
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in the booklet supplied with the kit were followed, except that other
microtiter platesi were used instead of those supplied with the kit. All
analyses were done in duplicate; readings were accepted only if they
differed by less than 10%. Only the average of the 2 readings is re-
ported here.
Echocardiographic Measurements
The video-recorded echocardiograms were later reviewed, with the
observer (HDP) being unaware of the identity and clinical findings of
the dogs. The degree of mitral valve prolapse (relative to the mitral
annular plane) was assessed by measuring the maximal protrusion (in
0.5-mm increments) of the anterior leaflet, the posterior leaflet, and
the coaption point (or the most protruding tip if the leaflets did not
coapt).8 Only the average of these 3 measurements is reported here.
The regurgitant jet area was estimated by eye as the percentage of the
left atrium that was occupied by the largest jet (to the nearest 5%).
The left ventricular end diastolic diameter (LVEDD) was measured at
the beginning of the QRS complex. The diameters of the left atrium
and the aortic root were measured shortly after ventricular systole,
when the left atrium was at its maximum diameter. A left atrial to
aortic root ratio (LA/Ao ratio) was calculated. The LVEDDs and LA/
Ao ratios reported here are averages of 5 consecutive heart cycles.
Statistical Analyses
All statistical calculations were performed with statistical software.j
The level of significance was P  .05. To test whether the different
disease-related variables (dog group [4 groups; see Table 1], jet size,
LVEDD, LA/Ao ratio, and murmur intensity) influenced the plasma
concentration of NOx, 5 multiple linear regression analyses were per-
formed, in which the disease-related variable in question was included
as an independent variable together with age, gender, serum creatinine
concentration, and platelet count. Except for the analysis with dog
group as independent variable, the analyses were performed only on
the 41 CKCSs. To compare the disease-related variables jet size, LA/
Ao ratio, murmur intensity, and LVEDD in pairs, 6 multiple linear
regression analyses were performed in which 2 disease-related vari-
ables (and the interaction between them) were the independent vari-
ables (together with age, gender, serum creatinine concentration, and
platelet count) and the plasma concentration of NOx was the response
variable. In all analyses, dog group, murmur intensity, and gender were
included as class variables, with the remaining explaining variables
included as continuous ones. Murmurs graded 3, 4, and 5 were ana-
lyzed together, and LVEDD was divided by body weight0.29, to nor-
malize it to the size of the dog.24 The models were gradually reduced
(by manual, backward selection) until only variables with statistically
significant effects remained. The residuals were tested for normality
and homogeneity of variation by Shapiro-Wilks test and residual plot,
respectively. A logarithmic transformation was used for NOx and a
square root transformation was used for LVEDD, to make the distri-
butions approximately normal.
Fisher’s exact test was used to assess differences between dog
groups with regard to gender distribution. To assess other differences
between dog groups, 1-way analyses of variance were performed. In
case of significant group effect, pairwise comparisons of the 4 groups
were made by using t-tests. The resulting P-values were corrected for
multiple testing by the Bonferroni method. In the group of 23 CKCSs
with no or minimal MR, Student’s t-test and simple linear regression,
respectively, were used to test whether presence of thrombocytopenia
(platelet count  100  109/L) and degree of mitral valve prolapse
influenced the plasma NOx concentration. Because the majority of the
data were not normally distributed, data are given as median values
and interquartile intervals unless otherwise stated.
Results
The 9 control dogs all had either no regurgitant jet (n 
7) or one occupying 10% of the left atrial area, and they
all had no heart murmur. Of the 23 CKCSs with no or
minimal MR, 13 dogs had no heart murmur, 9 had a grade
1 murmur, and 1 had a grade 2 murmur. Of the 9 dogs with
mild MR, 2 dogs had no heart murmur, 4 had a grade 2
murmur, and 3 had a grade 3 murmur. Of the 9 dogs with
moderate to severe MR, 1 dog had a grade 1 heart murmur,
2 had a grade 2 murmur, 2 had a grade 3 murmur, 3 had a
grade 4 murmur, and 1 had a grade 5 murmur. Eleven (27%)
of the 41 CKCSs had thrombocytopenia (100  109
platelets/L).
At the 9-month follow-up, 7 of the 9 CKCSs with mod-
erate to severe MR were clinically healthy. The remaining
2 dogs developed pulmonary hypertrophic osteoarthropathy
(n  1) and a cough likely related to heart disease (n 
1), 6 months after sampling. Except for the cough, the latter
dog (which on the day of blood sampling had a grade 5
murmur and a LA/Ao ratio of 1.74) was well without car-
diac medication at follow-up.
Compared with the 9 control dogs, the 23 CKCSs with
no or minimal MR had significantly lower body weight,
lower serum creatinine concentration, and higher degree of
mitral valve prolapse (Table 1). No other differences were
found between those 2 groups in the evaluated variables.
The CKCSs with mild MR only differed significantly from
the 23 CKCSs with no or minimal MR by having a higher
degree of mitral valve prolapse and a lower plasma con-
centration of NOx (Table 1; Fig 1). However, the CKCSs
with moderate to severe MR differed with regard to several
variables: they had higher age, higher platelet counts, high-
er degree of mitral valve prolapse, higher LA/Ao ratio, and
lower plasma NOx concentration (Table 1; Fig 1). A plate-
let count higher than 350  109/L was found in 3 (33%)
of the CKCSs with moderate to severe MR. Only 1 of the
remaining 41 dogs (a CKCS with mild MR) had such a
high platelet count. The CKCSs with moderate to severe
MR only differed significantly from the group of CKCSs
with mild MR by having a higher degree of mitral valve
prolapse and a higher LA/Ao ratio (Table 1).
In each of the 5 multiple regression analyses performed,
the only independent variables with significant influence on
the plasma concentration of NOx were the disease-related
variables. Significant associations were found between plas-
ma NOx and dog group (n  50, R2  0.24, P  .006),
jet size (n  41, R2  0.23, P  .002), LA/Ao ratio (n 
41, R2  0.19, P  .005), murmur intensity (n  41, R2
 0.17, P  .01), and LVEDD (n  41, R2  0.21, P 
.003). When the 4 disease-related variables jet size, LA/Ao
ratio, murmur intensity, and LVEDD were analyzed in
pairs, jet size outweighed the effects of the other 3 vari-
ables. The LVEDD outweighed the effects of LA/Ao ratio
and murmur intensity, and the LA/Ao ratio outweighed the
effects of murmur intensity. None of the interactions had
significant influence. Thus, jet size apparently had a stron-
ger influence on the plasma concentration of NOx than did
the other disease measures, including LA/Ao ratio (Figs 1
and 2a versus 2b).
Within the group of CKCSs with no or minimal MR, 8
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Fig 1. Plasma concentration of nitrate and nitrite (NOx) in control dogs and clinically healthy Cavalier King Charles Spaniels (CKCSs) with
different degrees of mitral regurgitation (MR). Dogs with mild and moderate to severe MR had regurgitant jets occupying 15–50% and 50%
of the left atrial area, respectively. NS, not significantly different; * P  .05.
dogs with thrombocytopenia had the same plasma concen-
tration of NOx (22.9 M; 16.5–25.6 M) as 15 dogs with-
out thrombocytopenia (17.7 M; 15.5–25.9 M) (P .95).
Furthermore, the mitral valve prolapse degree was not as-
sociated with the plasma NOx concentration (R2  0.0007;
P  .91).
Discussion
This study shows that the plasma concentration of NOx
is lower in CKCSs with mild to severe, clinically silent MR.
The study also shows that control dogs and CKCSs with
no or minimal MR have similar plasma concentrations of
NOx, and that neither the degree of mitral valve prolapse
nor the presence of clinically inapparent, inherited throm-
bocytopenia influenced NOx concentrations in the latter
group. The findings suggest that endothelial dysfunction de-
velops early in the course of developing MR in dogs.
Evidence supporting our finding of lower plasma NOx
concentrations in CKCSs with MR is persuasive. First, only
little a overlap in plasma NOx concentrations occurred be-
tween CKCSs with mild to severe MR and CKCSs with no
or minimal MR. Second, the plasma concentration of NOx
was significantly associated with all disease variables eval-
uated (albeit the R2 was low for all variables). Third, the
study conditions were highly standardized. The study was
based on dogs from 1 breed, with 1 disease, that received
no medication and had no renal problems. In addition, all
samples were taken after the dogs had been fed exclusively
NOx-free water and a diet with a low nitrate and nitrite
content for 4 days (only water for the last 24 hours)—a
protocol that should be more than sufficient to ensure that
the dietary intake of nitrate and nitrite had a low and con-
stant influence on the plasma NOx concentrations.15,17,19,20
Finally, the differences in potential confounders (eg, age,
gender, creatinine, blood urea nitrogen [BUN], and platelet
count) among the 3 groups of CKCSs were small and gen-
erally not significant (although CKCSs with moderate to
severe MR were older and had higher platelet counts than
the CKCS control group). Furthermore, because of the ob-
servation that the potential confounders had no influence in
any of the multiple regression analyses performed, the mi-
nor differences between the groups likely played no role
for the main conclusions of the study.
The fact that the majority of the dogs in this study were
active in the period leading up to the blood sampling (being
transported to the clinic and received and acclimatized
there) probably was a major factor that allowed the finding
of differences among the groups. The activity of the dogs
likely provided a long-lasting and widespread vasodilatory
stimulus—the kind of stimulus necessary for endothelial
dysfunction to be detected as a change in the NOx concen-
tration in the circulation.18,20 The stimulus needs to be wide-
spread because of the volume of distribution, and long-last-
ing to allow nitrate to accumulate (the majority of the NOx
found in blood is nitrate, which has a half-life in the cir-
culation of approximately 5–8 hours in humans14 and 4
hours in dogs18). The long half-life of nitrate implies that
the duration of the acclimatization period before blood sam-
pling only have had minor influence on the findings.
In humans, the degree of endothelial dysfunction has
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Fig 2. The plasma concentration of nitrate and nitrite (NOx) shown as a function of (A) the regurgitant jet size and (B) the left atrial to aortic
root ratio (LA/Ao ratio) in 41 clinically healthy Cavalier King Charles Spaniels (R2  0.23 and 0.19, respectively). LA, left atrium.
been found to increase with increasing degree of heart fail-
ure.6,7 In accordance with that, it appears from Figure 1 that
most of the dogs with a very low plasma NOx concentra-
tion (eg, 10 M) had severe MR. However, as a group,
the 9 dogs with moderate to severe MR were not signifi-
cantly different from the dogs with mild MR. Conclusions
are difficult to make from small groups, but a reason for
this could be that a few of the old, more diseased dogs had
other, undetected disorders that caused NOx accumulation.
However, note that most of the dogs with moderate to se-
vere MR still were clinically healthy at the 9-month follow-
up, and that the 2 dogs that did develop clinical problems
did so 6 months after the study. Another interesting finding
in this study with regard to the association between degree
of disease and plasma NOx concentration is that the NOx
concentration appeared to relate better to regurgitant jet size
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than to left atrial or left ventricular size. This likely reflects
that the degree of MR in most of the dogs was so mild that
the diameter of the left atrium and left ventricle were not
markedly changed yet.
Dogs with pacing-induced heart failure as well as hu-
mans with heart failure caused by different spontaneous
heart diseases have long been known to have endothelial
dysfunction.3,4 Recent studies in humans with different
heart diseases (including valvular ones) have shown that
endothelium-dependent vasodilation apparently is impaired
early in the course of developing heart failure.6,7 The find-
ings presented here show that the same is true for dogs with
MR. However, the argument could be made that CKCSs
might not be representative of all dogs with MR. On the
other hand, CKCSs without MR were found to have plasma
NOx concentrations similar to the concentrations found in
dogs from other breeds.
Nitrite and nitrate are excreted by the kidneys, and re-
duced renal function therefore leads to NOx accumulation
in the blood. Consequently, it is important that renal func-
tion is normal if the plasma concentration of NOx is used
to assess the NO turnover in the body. The importance of
this notion is underscored by the fact that dogs with pacing-
induced heart failure often have an increased plasma NOx
concentration because of this phenomenon.25 In the present
study, the majority of the dogs were young or middle-aged
and only clinically healthy dogs (ie, without signs of de-
compensated heart failure) were included. Furthermore,
none of the included dogs had high serum concentrations
of BUN and creatinine. The finding that control dogs had
higher serum creatinine concentrations than the CKCSs
merely reflects that the serum creatinine concentration is
higher in larger dogs than in small dogs.26
The CKCSs with moderate to severe MR had signifi-
cantly higher platelet counts than the CKCSs with no or
minimal MR. An explanation for this could be that this
group by chance included few dogs with inherited macro-
thrombocytopenia. However, this is likely not the only ex-
planation. It seems that something must have increased the
platelet count in the dogs in this group inasmuch as 3 of
the dogs (33%) had more than 350  109 platelets/L, a
level that is known from this and previous studies rarely to
be reached in CKCSs with no or mild MR.12,27 In addition,
in 2 of these 3 dogs, lower platelet counts (20 and 29%
lower) have been found previously by manual counting,
that is, at an earlier disease stage (data not shown). We
speculate that an explanation for the high platelet counts
could be platelet fragmentation caused by shear stress act-
ing on the regurgitating blood.28
From this study, no relationship is apparent between the
degree of mitral valve prolapse per se and the plasma NOx
concentration in CKCSs. In accordance with that, CKCSs
without MR (but usually with mitral valve prolapse) had
the same concentration of NOx in plasma as control dogs
without mitral valve prolapse. Therefore, findings such as
a high renin and low aldosterone profile and an increased
degree of respiratory sinus arrhythmia in dogs with mitral
valve prolapse likely do not reflect changes in the endothe-
lial NO production. In addition, the plasma concentration
of NOx appears to be unaffected by the presence or absence
of clinically inapparent, inherited thrombocytopenia. There-
fore, the recent finding of increased platelet reactivity in
CKCSs without thrombocytopenia (as compared with con-
trol dogs and CKCSs with thrombocytopenia)27 apparently
does not reflect changes in endothelial NO production.
With a decreased ability to produce NO, the endothelium
will have a reduced ability to limit platelet activation, ad-
hesion, and aggregation.29 This is probably a major reason
why a relationship is apparent between endothelial dys-
function and conditions such as atherosclerosis, thrombosis,
and intimal hyperplasia in humans.1,29,30 In that context, it
is interesting that CKCS have been found to develop inti-
mal hyperplasia in the femoral arteries as well as the main
pulmonary artery31,32 and that these vessel changes, as dis-
cussed elsewhere,8,9 in many ways resemble the changes
seen in myxomatous valve leaflets.
In patients with heart failure, an impaired endothelium-
dependent vasodilation will reduce exercise capacity and in-
crease the total peripheral resistance and thereby the left ven-
tricular afterload. Therefore, and because endothelium-de-
rived NO is known to be vasoprotective in many ways, cor-
rection of endothelial dysfunction is considered a major
therapeutic goal.5 Although much research is still needed,
many methods to improve endothelial dysfunction have
shown promising results in humans, including physical train-
ing, supplemental oral L-arginine, inhibition of angiotensin-
converting enzyme, use of antioxidants such as vitamin C,
growth hormone treatment, and endothelin-A receptor block-
ade.33–39 Study of the effects of these different treatments,
both on the plasma concentration of NOx and on the long-
term prognosis, in dogs with MR would be interesting. Study
of the effects of endothelin-receptor blockade perhaps would
be especially interesting, because endothelin may be an im-
portant pathogenetic factor not only in the general circula-
tion, but also locally in the valve leaflets.40
Based on this study it seems that it is relatively easy to get
an assessment of the endothelial-dependent vasodilation in
dogs. By using a simple standardized approach, it was possible
to detect statistically significant changes without including a
large number of patients. Therefore, the approach used in this
study can be used for further studies of the pathophysiology
of different heart diseases in dogs. In addition, the method can
be used to assess the effects of cardiac medication on early
stages of different heart diseases—before expensive and time-
consuming double-blind, placebo-controlled trials are initiated.
The only major weakness of the method appears to be its
sensitivity to impaired renal function.
Footnotes
a GLP diet, batch 000113390, Leo Pharmaceuticals, Ballerup, Denmark
b Milli-Q Gradient system, Millipore Corporation, Bedford, MA
c Venofix 21G (0.8  20 mm) 30 cm, B. Braun, Melsungen, Germany
d Vacuette, Greiner Bio-One, Kremsmu¨nster, Austria
e Unopette Microcollection System, Becton-Dickinson, Rutherford, NJ
f Vivid 3 echocardiograph, GE Medical, Milwaukee, WI
g Microcon YM-10 Microfilters, Millipore Corporation, Bedford, MA
h Nitrate/nitrite colorimetric assay kit, Cayman Chemical Company,
San Diego, CA
i Polypropylen microtiter plates, In Vitro as, Fredensborg, Denmark
j SAS Statistical Software, Version 8, SAS Institute, Cary, NC
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